UK markets close in 4 hours 47 minutes

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.5900+0.1200 (+4.86%)
At close: 04:00PM EDT
2.7000 +0.12 (+4.65%)
Pre-market: 04:00AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
31
30
30
38
Selling general and administrative
759
850
1,001
910
Total operating expenses
790
880
1,031
948
Operating income or loss
-790
-880
-1,031
-948
Total other income/expenses net
-1,428
-493
1,466
-2,034
Income before tax
-2,246
-1,348
435
-2,954
Income from continuing operations
-2,246
-1,348
435
-2,954
Net income
-2,246
-1,348
435
-2,954
Net income available to common shareholders
-2,246
-1,348
435
-2,954
Basic EPS
-0.40
-0.20
0.10
-0.60
Diluted EPS
-0.40
-0.20
0.07
-0.60
Basic average shares
5,449
5,449
5,320
5,142
Diluted average shares
5,449
5,449
6,155
5,142